Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 4/20 | 0.56 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.56 |
| ▸ | NPY1R | P25929 | 1/20 | 0.55 |
| ▸ | NPY2R | P49146 | 1/20 | 0.55 |
| ▸ | NPY4R | P50391 | 1/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Laminin SCHEMBL29354054 | 1.00 | NTSR1 (0.56) | NTSR1NTSR2NPY1RNPY2RNPY4R | |
| SCHEMBL29502171 | 0.92 | QRFPR (0.57) | NTSR1NTSR2NPY1RNPY2RNPY4R | |
| SCHEMBL29671012 | 0.90 | NTSR1 (0.54) | NTSR1NTSR2NPY1RNPY2RNPY4R | |
| SCHEMBL29472190 | 0.89 | OPRD1 (0.54) | NTSR1NTSR2OPRD1OPRM1OPRK1 | |
| Laminin SCHEMBL2182807 | 0.88 | OPRD1 (0.55) | NPY1RNPY2RNPY4ROPRD1OPRM1 | |
| Laminin SCHEMBL2182800 | 0.88 | OPRD1 (0.55) | NPY1RNPY2RNPY4ROPRD1OPRM1 | |
| SCHEMBL31756855 | 0.87 | NTSR1 (0.66) | NTSR1NTSR2NPY1RNPY2RNPY4R | |
| SCHEMBL29472198 | 0.86 | OPRD1 (0.58) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30887562 | 0.85 | OPRD1 (0.64) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29418259 | 0.83 | NPY1R (0.57) | NPY1RNPY2RNPY4ROPRD1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114207111-B | Method for producing skin-derived multipotent precursor cells | 花王株式会社 | 2025-05-30 | — | — | CN | claimed |
| CN-115516096-B | Chimeric proteins comprising fibrinogen and laminin fragments and uses thereof | 国立大学法人大阪大学 | 2024-10-29 | — | — | CN | claimed |
| US-20240117301-A1 | METHOD FOR PRODUCING PROLIFERATING CELLS, METHOD FOR PRODUCING CELL PRODUCT, MESENCHYMAL STEM CELL POPULATION AND METHOD FOR PRODUCING SAME, CULTURE SUPERNATANT OF STEM CELLS AND METHOD FOR PRODUCING SAME, AND THERAPEUTIC AGENT | CELL EXOSOME THERAPEUTICS INC (JP) | 2024-04-11 | — | — | US | claimed |
| US-20230203131-A1 | CHIMERIC PROTEIN COMPRISING A FIBRINOGEN FRAGMENT AND A LAMININ FRAGMENT AND USE THEREOF | OSAKA UNIVERSITY (JP) | 2023-06-29 | — | — | US | claimed |
| US-20230172992-A1 | METHOD FOR PRODUCING PROLIFERATING CELLS, METHOD FOR PRODUCING CELL PRODUCT, MESENCHYMAL STEM CELL POPULATION AND METHOD FOR PRODUCING SAME, CULTURE SUPERNATANT OF STEM CELLS AND METHOD FOR PRODUCING SAME, AND THERAPEUTIC AGENT | CELL EXOSOME THERAPEUTICS INC. (JP) | 2023-06-08 | — | — | US | claimed |
| CN-116179480-A | Method for producing proliferating cells and cell products, mesenchymal stem cell population and stem cell culture supernatant, method for producing the same, and therapeutic agent | 细胞外泌体治疗有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-108350417-B | Cell culture method using culture medium containing laminin fragments | 国立大学法人京都大学 | 2023-04-11 | — | — | CN | claimed |
| EP-4155389-A2 | METHOD OF PRODUCING PROLIFERATED CELLS, METHOD OF PRODUCING CELL PRODUCT, MESENCHYMAL STEM CELL POPULATION AND METHOD OF PRODUCING SAME, CULTURE SUPERNATANT OF STEM CELLS AND METHOD OF PRODUCING SAME, AND THERAPEUTIC AGENT | Cell Exosome Therapeutics Inc. (JP) | 2023-03-29 | — | — | EP | claimed |
| EP-4148133-A1 | CHIMERIC PROTEIN CONTAINING FIBRINOGEN FRAGMENT AND LAMININ FRAGMENT, AND USE THEREOF | OSAKA UNIVERSITY (JP) | 2023-03-15 | — | — | EP | claimed |
| US-20230069065-A1 | NOVEL CORNEAL TISSUES AND METHODS OF MAKING THE SAME | 3D BIO TISSUES LTD (GB) | 2023-03-02 | — | — | US | claimed |
| CN-115362252-A | Method for producing proliferating cell and cell product, mesenchymal stem cell population and stem cell culture supernatant, method for producing same, and therapeutic agent | 细胞外泌体治疗有限公司 | 2022-11-18 | — | — | CN | claimed |
| US-20220340868-A1 | METHOD FOR PREPARING SKIN-DERIVED PLURIPOTENT PRECURSOR CELLS | KAO CORPORATION (JP) | 2022-10-27 | — | — | US | claimed |
| US-20220296774-A1 | SUPRAMOLECULAR STRUCTURES | CELLULAREVOLUTION LTD (GB) | 2022-09-22 | — | — | US | claimed |
| CN-114901811-A | Novel corneal tissue and method for producing the same | 3D细胞生物有限公司 | 2022-08-12 | — | — | CN | claimed |
| EP-3375863-B1 | CELL CULTURE METHOD USING LAMININ FRAGMENT-CONTAINING MEDIUM | UNIV KYOTO (JP) | 2022-08-03 | — | — | EP | claimed |
| EP-4012022-A1 | METHOD FOR PRODUCING SKIN-DERIVED PLURIPOTENT PROGENITOR CELLS | Kao Corporation (JP) | 2022-06-15 | — | — | EP | claimed |
| WO-2022080473-A1 | NERVE CELL ACTIVATOR | 三沢幸子 | 2022-04-21 | — | — | WO | claimed |
| EP-3983427-A1 | SUPRAMOLECULAR STRUCTURES | Cellularevolution Limited (GB) | 2022-04-20 | — | — | EP | claimed |
| CN-114341173-A | Supramolecular structures | 细胞进化有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114207111-A | Method for preparing skin-derived pluripotent precursor cells | 花王株式会社 | 2022-03-18 | — | — | CN | claimed |